Matrix Asset Advisors’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-318,813
| Closed | -$8.08M | – | 110 |
|
|
2025
Q1 | $8.08M | Buy |
318,813
+65,535
| +26% | +$1.71M | 0.89% | 41 |
|
|
2024
Q4 | $6.72M | Sell |
253,278
-38,127
| -13% | -$1.03M | 0.73% | 42 |
|
|
2024
Q3 | $8.43M | Sell |
291,405
-5,851
| -2% | -$171K | 0.94% | 39 |
|
|
2024
Q2 | $8.32M | Buy |
297,256
+19,377
| +7% | +$533K | 0.99% | 36 |
|
|
2024
Q1 | $7.71M | Buy |
277,879
+69,339
| +33% | +$1.92M | 0.92% | 37 |
|
|
2023
Q4 | $6M | Buy |
208,540
+14,305
| +7% | +$432K | 0.76% | 41 |
|
|
2023
Q3 | $6.44M | Buy |
194,235
+80,761
| +71% | +$2.86M | 0.92% | 40 |
|
|
2023
Q2 | $4.16M | Buy |
+113,474
| New | +$4.42M | 0.57% | 45 |
|
|
2019
Q4 | – | Sell |
-5,951
| Closed | -$203K | – | 77 |
|
|
2019
Q3 | $203K | Sell |
5,951
-212,855
| -97% | -$7.74M | 0.04% | 71 |
|
|
2019
Q2 | $8.99M | Buy |
218,806
+555
| +0.3% | +$22K | 1.59% | 32 |
|
|
2019
Q1 | $8.79M | Sell |
218,251
-1,689
| -0.8% | -$67.6K | 1.5% | 34 |
|
|
2018
Q4 | $9.11M | Sell |
219,940
-26,588
| -11% | -$1.1M | 1.69% | 25 |
|
|
2018
Q3 | $10.3M | Sell |
246,528
-15,590
| -6% | -$600K | 1.64% | 25 |
|
|
2018
Q2 | $9.02M | Sell |
262,118
-1,923
| -0.7% | -$65.7K | 1.49% | 30 |
|
|
2018
Q1 | $8.89M | Buy |
264,041
+4,491
| +2% | +$154K | 1.47% | 30 |
|
|
2017
Q4 | $8.92M | Buy |
259,550
+6,321
| +2% | +$216K | 1.42% | 31 |
|
|
2017
Q3 | $8.58M | Buy |
253,229
+4,790
| +2% | +$154K | 1.41% | 32 |
|
|
2017
Q2 | $7.92M | Buy |
248,439
+10,685
| +4% | +$337K | 1.36% | 33 |
|
|
2017
Q1 | $7.72M | Buy |
237,754
+20,902
| +10% | +$659K | 1.36% | 34 |
|
|
2016
Q4 | $6.68M | Buy |
216,852
+21,168
| +11% | +$646K | 1.13% | 38 |
|
|
2016
Q3 | $6.29M | Buy |
195,684
+29,036
| +17% | +$971K | 1.11% | 37 |
|
|
2016
Q2 | $5.57M | Buy |
166,648
+1,819
| +1% | +$58.1K | 1.08% | 37 |
|
|
2016
Q1 | $4.63M | Buy |
164,829
+17,347
| +12% | +$496K | 0.91% | 39 |
|
|
2015
Q4 | $4.52M | Buy |
147,482
+4,008
| +3% | +$126K | 0.87% | 38 |
|
|
2015
Q3 | $4.28M | Buy |
143,474
+3,344
| +2% | +$107K | 0.61% | 37 |
|
|
2015
Q2 | $4.46M | Buy |
140,130
+11,922
| +9% | +$389K | 0.56% | 39 |
|
|
2015
Q1 | $4.23M | Buy |
128,208
+1,091
| +0.9% | +$34.7K | 0.49% | 42 |
|
|
2014
Q4 | $3.76M | Buy |
127,117
+12,462
| +11% | +$357K | 0.42% | 47 |
|
|
2014
Q3 | $3.22M | Buy |
114,655
+4,624
| +4% | +$130K | 0.37% | 47 |
|
|
2014
Q2 | $3.1M | Buy |
110,031
+15,582
| +16% | +$444K | 0.35% | 47 |
|
|
2014
Q1 | $2.88M | Buy |
94,449
+1,401
| +2% | +$41.8K | 0.34% | 45 |
|
|
2013
Q4 | $2.7M | Buy |
93,048
+17,312
| +23% | +$504K | 0.33% | 46 |
|
|
2013
Q3 | $2.06M | Buy |
75,736
+2,985
| +4% | +$81.2K | 0.28% | 47 |
|
|
2013
Q2 | $1.93M | Buy |
+72,751
| New | +$2.01M | 0.27% | 48 |
|
Other funds holding PFE
Matrix Asset Advisors's PFE Position: Q2 2025 in Review
Matrix Asset Advisors sold out of Pfizer (PFE) in Q2 2025, closing a stake of 318,813 shares — an estimated $8.08M sold.
Matrix Asset Advisors first reported a position in PFE in Q2 2013 and held it in 34 quarters. The position peaked at $10.3M in Q3 2018. 2,809 funds tracked by Wall St. Rank hold PFE as of Q2 2025.
- Matrix Asset Advisors reported no remaining Pfizer position as of Q2 2025 after selling out during the quarter.
- Matrix Asset Advisors sold 318,813 Pfizer shares in Q2 2025, an estimated $8.08M.
- Matrix Asset Advisors first reported a position in Pfizer in Q2 2013 and held it in 34 quarters.
- Matrix Asset Advisors's Pfizer position peaked at $10.3M in Q3 2018.
- 2,809 funds tracked by Wall St. Rank held Pfizer as of Q2 2025.
Based on Matrix Asset Advisors's 13F filing for Q2 2025, filed 25 Jul 2025.